Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: CRISPR THERAPEUTICS INC., CRISPR THERAPEUTICS, INC., CRISPR THERAPEUTICS, INC.
Client-Reported Lobbying Expenses
$1.1M
61 filings
Firm Income Reported for This Client
$990K
Not substituted for client expenses
Summary
CRISPR THERAPEUTICS, INC. is an organization, based in MA. Its political footprint includes $1.1 million in client-reported lobbying expenses, $990K in lobbying-firm income reported for this client. Lobbying activity focuses on Medicare/Medicaid, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs. Political activity spans from 2019 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: Senate LDA